Lantern Pharma Investor Relations Material
Latest events
Q1 2025
Lantern Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lantern Pharma Inc
Access all reports
Lantern Pharma Inc. is a clinical-stage biotechnology company focused on leveraging artificial intelligence and genomic data to develop precision oncology therapeutics. The company’s pipeline targets a range of cancers with the aim of enhancing treatment outcomes and reducing development risks. Lantern Pharma Inc. is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Key slides for Lantern Pharma Inc
Q1 2025
Lantern Pharma Inc
Q1 2025
Lantern Pharma Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
LTRN
Country
🇺🇸 United States